Hydroxyurea in the treatment of high-risk essential thrombocythaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hydroxyurea in the Treatment of High-risk Essential Thrombocythaemia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450609/all/Hydroxyurea_in_the_treatment_of_high_risk_essential_thrombocythaemia.
Hydroxyurea in the treatment of high-risk essential thrombocythaemia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450609/all/Hydroxyurea_in_the_treatment_of_high_risk_essential_thrombocythaemia. Accessed September 12, 2024.
Hydroxyurea in the treatment of high-risk essential thrombocythaemia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450609/all/Hydroxyurea_in_the_treatment_of_high_risk_essential_thrombocythaemia
Hydroxyurea in the Treatment of High-risk Essential Thrombocythaemia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450609/all/Hydroxyurea_in_the_treatment_of_high_risk_essential_thrombocythaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hydroxyurea in the treatment of high-risk essential thrombocythaemia
ID - 450609
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450609/all/Hydroxyurea_in_the_treatment_of_high_risk_essential_thrombocythaemia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -